Markets:

Overview

News

Currencies

International

Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

29.86 -2.15 (-6.72%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stocks That Hit 52-Week Lows On Friday ↗

January 14, 2022

During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...

Via Benzinga

Twist Bioscience’s Comprehensive DNA Synthesis Capabilities Expanded as Industry-Leading Enzymatic Synthesis Process Unveiled at Annual J.P. Morgan Healthcare Conference

January 10, 2022

From Twist Bioscience Corporation

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

January 06, 2022

On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this...

Via Benzinga

Twist Bioscience Creates Custom Whole Exome Target Enrichment Panel for Canine Genomic Research

January 06, 2022

From Twist Bioscience Corporation

Via Business Wire

Revelar Biotherapeutics and Twist Bioscience Announce RBT-0813 Neutralizes SARS-CoV-2 Omicron (B.1.1.529/BA.1) and Delta (B.1.617.2) Variants

January 05, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 04, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches 96-Plex Library Prep Kit for Low Pass High Throughput Next-Generation Sequencing

December 20, 2021

From Twist Bioscience Corporation

Via Business Wire

Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop Novel Therapeutic Antibodies Against GPCR Targets

December 16, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Omicron (B.1.1.529/BA.1) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests

December 15, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches Circulating Tumor DNA Reference Controls for Development of Liquid Biopsy Assays

December 07, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Announces Participation in SRC-SIA Webinar on the Decadal Plan for Semiconductors

November 30, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Present at Upcoming Virtual Conferences

November 24, 2021

From Twist Bioscience

Via Business Wire

Why Are Twist Bioscience Shares Plunging Today? ↗

November 22, 2021

Twist Bioscience Corporation (NASDAQ: TWST) reported a 17% Y/Y increase in its Q4 revenues to $37.95 million, beating the Wall Street estimate of $37.02 million, driven...

Via Benzinga

Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results

November 22, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities

November 22, 2021

From Twist Bioscience Corporation

Via Business Wire

Earnings Scheduled For November 22, 2021 ↗

November 22, 2021

Companies Reporting Before The Bell • Cerence (NASDAQ:CRNC) is estimated to report quarterly earnings at $0.56 per share on revenue of $97.92 million. • Avaya...

Via Benzinga

The Week Ahead In Biotech (Nov. 21-Nov. 27): FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week ↗

November 21, 2021

Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting...

Via Talk Markets

The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week ↗

November 21, 2021

Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the...

Via Benzinga

Earnings Preview For Twist Bioscience ↗

November 19, 2021

Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Monday, 2021-11-22. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Twist Bioscience Expands Partnership with Invetx to Include Discovery of Best-in-Class Antibodies to Treat Multiple Diseases in Cats and Dogs

November 18, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases

November 15, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Present at the Stifel 2021 Virtual Healthcare Conference

November 09, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Named in Inc.’s First Annual Best-Led Companies List

November 02, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Report Fiscal 2021 Fourth Quarter and Full Year Financial Results on Monday, November 22, 2021

November 01, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches Exome 2.0 for Genomics Research

October 20, 2021

From Twist Bioscience Corporation

Via Business Wire

Week In Review: Hansoh Signs $456 Million Deal For siRNA Products ↗

October 16, 2021

Hansoh Pharma of Shanghai announced a $456 million agreement to develop siRNA products in Greater China from South Korea's OliX Pharma. Hansoh will make an upfront payment of $6.5 million and up to...

Via Talk Markets

Twist Bioscience and the Broad Institute Create Custom Whole Exome Target Enrichment Panel for Clinical Research

October 13, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Appoints Steffen Hellmold as Senior Vice President, Business Development, Data Storage

October 12, 2021

From Twist Bioscience Corporation

Via Business Wire

Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases ↗

October 06, 2021

Centogene NV (NASDAQ: CNTG) and Twist Bioscience Corporation (NASDAQ: TWST) have signed a contract to develop and commercialize custom assay kits for rare diseases. The...

Via Benzinga

Twist Bioscience and CENTOGENE to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases

October 06, 2021

From Twist Bioscience Corporation

Via Business Wire

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.